Bullish Points: 1. Rhythm Pharmaceuticals is a commercial-stage biopharmaceutical company focused on therapeutics for rare genetic diseases of obesity. 2. Their lead product, IMCIVREE (setmelanotide), is approved in the United States for chronic weight management in patients with obesity due to POMC, PCSK1, or LEPR deficiency. 3. The company is also developing setmelanotide for the treatment of additional rare genetic diseases of obesity, including Alström syndrome, Bardet-Biedl syndrome, and other syndromic and non-syndromic diseases of obesity. 4. Over 425 prescriptions for IMCIVREE for BBS were written in the US from FDA approval through June 30, 2023. 5. FDA granted setmelanotide Breakthrough Therapy designation for the treatment of obesity associated with genetic defects upstream of t
Price alerts reflecting setups breaking through their range
SPX$S&P 500(.SPX)$ getting rejected at mid-term downtrend line with green to red action. if further downside reaction persist from tomorrow's NFP, not silly to take some chips off the tableDefinitely a good habit to spend a few minutes daily to journal down some thoughts, and remain focus to yr thought processesquite an insane no. of price alerts reflecting setups breaking through their rangelistening to setups is an indicator of the market strength$Sunrun(RUN)$$Rhythm Pharmaceuticals Inc.(RYTM)$$Veracyte(VCYT)$$Century Aluminum(CENX)$
General market is definitely in downtrend. but i do still take opportunities when stocks appear with relative strength. trading above 200MA is a sign of RS when indexes are below 200MA. What is different is i take lower risk (via smaller sizing) on such opportunitiesBear markets have two components: Price and Time. Price takes your money. Time takes your patience; all those rallies that turn out not to be the beginning of a new bull market, even though so many people think/wish they were, eventually just wear almost everybody out.You grow so much more as a trader in technical execution, risk management, and emotional control from cycle of corrections, than periods of market rally.Turn up daily, embrace the experience. you will thrive eventually.There is unquestionable euphoria with positiv
Bear markets have two components: Price and Time. Price takes your money. Time takes your patience; all those rallies that turn out not to be the beginning of a new bull market, even though so many people think/wish they were, eventually just wear almost everybody out.You grow so much more as a trader in technical execution, risk management, and emotional control from cycle of corrections, than periods of market rally.Turn up daily, embrace the experience. you will thrive eventually.There is unquestionable euphoria with positive market swing over the last few sessions, but the quality trades have already affirmed its relative strength in the first 2 weeks of the month. The best stocks bottom before the marketHere are the hot stocks that I think are important today, and I want to show them
Bear markets have two components: Price and Time. Price takes your money. Time takes your patience; all those rallies that turn out not to be the beginning of a new bull market, even though so many people think/wish they were, eventually just wear almost everybody out.You grow so much more as a trader in technical execution, risk management, and emotional control from cycle of corrections, than periods of market rally.Turn up daily, embrace the experience. you will thrive eventually.There is unquestionable euphoria with positive market swing over the last few sessions, but the quality trades have already affirmed its relative strength in the first 2 weeks of the month. The best stocks bottom before the marketHere are the hot stocks that I think are important today, and I want to show them
Bear markets have two components: Price and Time. Price takes your money. Time takes your patience; all those rallies that turn out not to be the beginning of a new bull market, even though so many people think/wish they were, eventually just wear almost everybody out.You grow so much more as a trader in technical execution, risk management, and emotional control from cycle of corrections, than periods of market rally.Turn up daily, embrace the experience. you will thrive eventually.There is unquestionable euphoria with positive market swing over the last few sessions, but the quality trades have already affirmed its relative strength in the first 2 weeks of the month. The best stocks bottom before the marketHere are the hot stocks that I think are important today, and I want to show them
Biotech Stocks Well-Positioned For Fourth Quarter: XBI, IBB, LABU
Summary Biotechs are relatively better positioned in this fourth quarter compared to the broader market. Path of interest rates is clearer for 2022 and the Fed is closer to a pause early next year as it calibrates down its response from a hammer approach. Biotechs benefit if a slowdown pushes the longer-term yields lower. M&A, partnerships, and breakthrough treatments provide further support. However, 10-year yields must stabilize and trend down for longer-lasting gains. Biotech PulseBiotechs have been outperforming the broader market in this decline phase of the bear market. While most major indexes made new lows for the year or retested prior lows set in June, biotech indexes have resisted declining backto those lows for now even though yields have soared past the June highs. The bio
Chart illustrates popular stock performance-CCRN,SG,RYTM&MIR
grow so much more as a trader in technical execution, risk management, and emotional control from cycle of corrections, than periods of market rally.turn up daily, embrace the experience. you will thrive eventually.Here are the hot stocks that I think are important today, and I want to show them in chart form：$Cross Country Healthcare(CCRN)$$Sweetgreen, Inc.(SG)$$Rhythm Pharmaceuticals Inc.(RYTM)$$GS Acquisition Holdings Corp(MIR)$ https://twitter.com/jeffsuntrading/status/1579086366545043463
we are in a period where market reacts negatively to good news1. September 2022 (Month #71)Total Trades: 23 (YTD 255 Trades)Month Absolute Gain (Loss): -$42,841.38Month Nett Dividends: +$6,343.13Month Return: -3.03% (YTD: +8.82%)Cumulative Return: +360.99% (Annualized: +29.95%)Win Rate: 43.14%Gain to Pain: 2.44Monthly Standard Deviation: 8.88%Sharpe Ratio: 0.97Sortino Ratio 1.88Gap Losses in $LSB Industries Inc(LXU)$$Sunrun(RUN)$$Zai Lab Ltd(ZLAB)$. Brings Lesson On Market Headliner Precedence Over Relative Strength 2.Chart illustrates popular stock performance-$Sweetgreen, Inc.(SG)$
Chart illustrates popular stock performance-CANO,RYTM,WFRD,CPNG,SG,YPF&FFTY
a quantitative way to a fuss-free approach in your trading during this bear mkt.precision in market timing is very valuable during this painful transition. the highly volatile environment will present a vastly diff in P&L % chng day-day.for present situation, the best setups have already taken off on its own trajectory from last friday.opportunities setting up every other day later is only presenting itself for a higher rate of failure (higher risk)already profit taking time, the market is moving that fast.remain sensible with your money management, ensuring that you trade small relative to the risk capital.the number one objective in trading is survival, this will never change in any environment1.SPX$S&P 500(.SPX)$ remains trapped within
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is in Phase 3 clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, and other MC4R disorders. The company has licensing agreements with LG Chem, Ltd; Ipsen Pharma S.A.S; Camurus; RareStone Group Ltd.; joint research collaboration with Axovia Therapeutics for developing in bardet-biedl syndrome; and LG Chem, Ltd. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.